Kynurenines: neuroactive compounds in the central nervous system : an in vitro study by Rózsa, Éva
V o l u m e 52{2):333-356. 2008 
Acta B io log ica Szegediens i s 
http:ZAwwvv.sci.u-szeged.hu/ABS 
taxonomical groups were selected, and used for the molecular studies. All species used were documented with light and scanning electron 
microscope images. Distance and likelihood based methods were used in combination with our own and GenBank sequences to determine 
the genetic similarity between oribatid mites at family level. 
Our results suggest that the similarity of 28S ribosomal DNA sequences support the monophyly of lower, but not higher oribatid 
groups. Cytochrome-oxidase (Coxl ) sequences are known to be useful at taxonomical level of genera. We introduced C o x l sequence in 
the identification of larva stages. 
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Kynurenic acid (KYNA) is a neuroprotective endogenous tryptophan metabolite produced by astrocytes and neurons via the kynurenine 
pathway in both humans and rodents. At non-physiological concentrations. KYNA is an excitatory amino acid receptor antagonist that 
can partially act at both the a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and N-methyl-D-aspartate subunits of the glutamate 
receptors (Stone 1993). 
In the brain. KYNA is synthesized in astrocytes from its bioprecursor L-kynurenine (KYN) and is then rapidly released into the extra-
cellular compartment. Previous studies have indicated that rat cortical slices have also the ability to synthesize KYNA from exogenously 
added KYN (Turski et al. 1989). The synthesis of KYNA from KYN is catalysed by kynurenine aminotransferase I and II (KAT I and II) 
(Schwarcz et al. 2002). 
The use of KYNA as a neuroprotective agent is rather restricted, however, because KYNA has only a very limited ability to cross the 
blood-brain barrier (Fukui et al. 1991). In contrast. KYN and different synthetic KYNA derivatives cross this barrier more readily (Giles 
et al. 2003). 
In the course of the experiments on rat brain slices, the Schaffer collaterals were stimulated and field excitatory postsynaptic potentials 
( fEPSPs) were recorded in the pyramidal layer of the hippocampal CA1 region. To test the effects of KYNA. we used an in vitro pentyle-
netetrazole (PTZ) model. PTZ, a chemical convulsant frequently utilized in the study of seizures (Yudkoff et al. 2006), exerts its effects by 
binding to the picrotoxin binding site of the post-synaptic GABA-A receptor (Macdonald et al. 1977). PTZ administered in vitro at I m M 
induced a considerable increase in the amplitude of the fEPSPs recorded from the hippocampal CA1 region. When applied locally in an 
extremely high concentration (20 mM). PTZ resulted in characteristic wavelets. However. KYNA administration not only decreased the 
amplitude of the hippocampal CA I responses evoked by Schaffer collateral stimulation, but also afforded protection from the PTZ-induced 
response enhancement. 
The KYNA precursor KYN also blocked the development of the PTZ-induced high increase in amplitude. To prove that the KYN—»KYNA 
conversion did take place in our experiments and that it was KYNA which afforded the protection against the effects of PTZ. we applied 
A'-omega-nitro-l-arginine. an inhibitor of KAT I and II (Rozsa et al. 2008). 
SZR-72, a synthetic kynurcnic acid derivative, applied in vitro, prooved to be also effective in preventing the high increase in f E P S P 
amplitudes, generated by PTZ. 
These findings show that treatment with KYN. or the synthetic kynurenic acid derivative, SZR-72. even at very low concentration, 
has an effect on enhanced neural excitability and thus support the hypothesis that manipulations of the kynurenine pathway might be a 
rewarding target in different neuronal disorders affected by neuronal hyperexcitation. 
Additionally we have shown, that KYNA in submicromolar concentration range has a positive neuromodulatory effect. In nM concen-
trations. kynurenic acid does not give rise to inhibition, but in fact facilitates the field excitatory postsynaptic potentials, recorded from the 
hippocampal CA1 region (Rozsa et al. 2008). 
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Methylococcus capsulatus (Bath) is a Gram-negative, methylotrophie bacterium, which oxidizes methane to carbon dioxide for energy 
generation. The enzyme complexes methane monooxygenases (MMOs) oxidize methane to methanol and co-oxidize a wide variety of 
aliphatic, aromatic and halogenated hydrocarbons, therefore they are extremely versatile enzymes for biocatalysis and bioremediation. The 
in vivo electron donor of the MMOs is NADH. which must be regenerated. Since biodegradation processes using M M O are co-oxidation 
processes, alternative ways of supplying reducing power are needed. Possible candidate could be H2 for NADH + H* generation. 
Hydrogenases are metalloenzymes catalyzing the reversible oxidation of H,. M. capsulatus (Bath) contains a soluble (Hox) hydrogenase 
- which is able to reduce NAD* using H, - , and a membrane-bound nickel-iron Hup hydrogenase - which plays an important role in the 
recycling of hydrogen, and maybe donates the electrons to the quinone pool. Another enzyme - nitrogenase - produces H, as a byproduct 
under nitrogen fixing condition. 
AhupSL and AhoxH deletion mutants were generated (Csáki et al. 2001). H,-driven M M O activities of these mutants and wild type 
were measured to obtain information about the in vivo function of the hydrogenases (Hanczár et al. 2002). The deletion mutants revealed 
unexpected behavior: the AhupSL mutant did not show H,-driven M M O activity, while the AhoxH mutant showed. The Hup hydrogenase 
- which is unable to reduce NAD* directly - is required for the H,-driven activity of MMO. To understand the role of Hup hydrogenase in 
H,-metabolism the first step is to find all genes coding for proteins, which has any affect on Hup hydrogenase activity. 
Several Hup phenotype mutants were isolated from a M. capsulatus random mutant library, which was generated by transposon mu-
tagenesis. The transposon was found in a structural gene (hupL ) , in an accessory gene ( h u p D ) of Hup hydrogenase, and in other genes: 
TonB-dependent receptor-like putative protein coding gene ( tonB) and conserved hypothetical protein for NADH ubiquinone/plastoquinone 
complex coding gene ( n u p X ) . 
The in vivo H , production capacities of the wild type and the mutant strains were compared. The Hup hydrogenase of the wild type 
consumed a lot of H, from the gas phase, while the mutants had lower H2 consumption activity both under nitrogen fixing and nitrogenase 
repressed conditions. Hup hydrogenase structural proteins were detected both in wild type. H u p D , TonB and NupX transposon mutants 
with HupL antibody by Western Blot assay, in contrast to the AhupSL deletion and HulpL transposon mutants. 
The results show the presence of the matured Hup hydrogenase in TonB and NupX transposon mutants, but hydrogen-metabolism of 
these mutants is damaged, therefore they have Hup phenotype. According to the in silico analysis and global protein alignment the proteins of 
the nupX containing operon are similar to the NuoM. NuoL and NuoN proteins of the NUO (NADH ubiquinon-plastoquinon oxydoreductase) 
complex. In our hypothesis the proteins of the examined nuo-like operon maybe play a role in the energy conversion of the bacterium, while 
the examined TonB-dependent receptor-like putative protein perhaps takes pan in the mechanism of TonB-catalyzed iron transport through 
the bacterial cell envelope, indirectly contributing to the assembly of the membrane-bound nickel-iron Hup hydrogenase. 
To determine the role of the mutant genes further investigations are needed. 
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